UNICEF in negotiations to buy COVID-19 drug for 4.5 million patients in poor countries
The initial purchase will be made for up to 4.5 million people in low and middle-income countries.
The initial purchase will be made for up to 4.5 million people in low and middle-income countries.
The researchers behind it suggest that the drug could become a standard medication.
The drug, which cost a patient less than N2,500 has proven to reduce the risk of dying.